Our Leaders

Servier’s ambition to improve patient care comes from the top. Our best-in-class executives pave the way for success.

David K. Lee
David K. Lee
Chief Executive Officer
Michael Bolton
Michael Bolton
General Counsel
Adam Camiel
Adam Camiel Headshot
Chief of Staff
Lynne Kelley
Lynne Kelley
Chief Medical Officer
Erik Lemay
Erik Lemay
Head of Technical Operations
Robert Paglia
Robert Paglia
Head of Market Access
Rekha Paleyanda
Rekha Paleyanda
Director of U.S. Business Development and Licensing
Wendy Poage
Wendy Poage
Head of Patient Advocacy
Deniz Razon
Deniz Razon
Head of Corporate Development
Kelly Schlemm
Kelly Schlemm
Head of Communications and Public Affairs
Christian Schubert
Christian Schubert
Global Head of External Innovation and Director of Servier BioInnovation
Samantha Small
Samantha Small
Strategy and Operations Lead
Latarsha Stewart
Latarsha Stewart
Head of Compliance
Eli Taube
Eli Taube
Head of the North America Clinical Operations Hub
Bart Van Rhijn
Bart Van Rhijn
Head of Finance
Donna Vieraitis
Donna Vieraitis
Head of Human Resources
Mark Yunger
Mark Yunger
Head of Information Technology

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on Oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More

Governance

Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More

History

Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More